Literature DB >> 1929540

Skin levels of vasoactive intestinal polypeptide in atopic dermatitis.

C Pincelli1, F Fantini, P Romualdi, G Lesa, A Giannetti.   

Abstract

Atopic dermatitis (AD) can be exacerbated by various factors, including emotional stress, scratching and sweating. The aim of the present study was to evaluate the hypothesis that the inflammatory reaction in AD is also neurogenic. For this purpose, the levels of vasoactive intestinal polypeptide were measured radioimmunologically in whole-tissue homogenates of lesional skin of 13 patients with atopic dermatitis. Radioimmunoassay was performed using an antiserum, AH78, recognizing the carboxy-terminal fragment vasoactive intestinal polypeptide (22-28). Vasoactive intestinal polypeptide immunoreactivity was detected in relatively low amounts in control skin (0.428 +/- 0.08 pmol/g tissue), whereas a marked increase in the peptide was observed in lesional skin of patients with atopic dermatitis (5.62 +/- 1.25 pmol/g tissue). These results seem to suggest that vasoactive intestinal polypeptide could have a pathogenetic relevance in skin lesions of atopic dermatitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1929540     DOI: 10.1007/bf01106107

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  20 in total

1.  PERIPHERAL VASCULAR RESPONSES IN ATOPIC DERMATITIS. THE INFLUENCE OF ENVIRONMENTAL TEMPERATURE CHANGES.

Authors:  G ABRAMS; E M FARBER
Journal:  Arch Dermatol       Date:  1963-11

2.  The structure of normal skin and the morphology of atopic eczema.

Authors:  M C Mihm; N A Soter; H F Dvorak; K F Austen
Journal:  J Invest Dermatol       Date:  1976-09       Impact factor: 8.551

3.  On definition and framework of atopic dermatitis.

Authors:  G Rajka
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1989

4.  Evaluation and relevance of atopic basic and minor features in patients with atopic dermatitis and in the general population.

Authors:  T L Diepgen; M Fartasch; O P Hornstein
Journal:  Acta Derm Venereol Suppl (Stockh)       Date:  1989

5.  Cytochemical localization of VIP-stimulated adenylate cyclase activity in human sweat glands.

Authors:  H Tainio
Journal:  Br J Dermatol       Date:  1987-03       Impact factor: 9.302

6.  A specific radioimmunoassay for the novel opioid peptide dynorphin.

Authors:  V E Ghazarossian; C Chavkin; A Goldstein
Journal:  Life Sci       Date:  1980-07-07       Impact factor: 5.037

Review 7.  Atopic dermatitis.

Authors:  J M Hanifin
Journal:  J Allergy Clin Immunol       Date:  1984-02       Impact factor: 10.793

8.  VIP-immunoreactivity in the skin of various mammals: immunohistochemical, radioimmunological and experimental evidence for a dual localization in cutaneous nerves and merkel cells.

Authors:  W Hartschuh; M Reinecke; E Weihe; N Yanaihara
Journal:  Peptides       Date:  1984 Mar-Apr       Impact factor: 3.750

Review 9.  [Neuropeptides and the skin: morphological, functional and physiopathological aspects].

Authors:  G Girolomoni; A Giannetti
Journal:  G Ital Dermatol Venereol       Date:  1989-04       Impact factor: 2.011

10.  Vasoactive intestinal polypeptide (VIP)-like immunoreactivity in the nerves of human axillary sweat glands.

Authors:  A Vaalasti; H Tainio; L Rechardt
Journal:  J Invest Dermatol       Date:  1985-09       Impact factor: 8.551

View more
  3 in total

1.  Role of parasympathetic nerves and muscarinic receptors in allergy and asthma.

Authors:  Gregory D Scott; Allison D Fryer
Journal:  Chem Immunol Allergy       Date:  2012-06-26

2.  Percutaneous absorption and anti-inflammatory effect of a substance P receptor antagonist: spantide II.

Authors:  R Jayachandra Babu; Loice Kikwai; Lasha T Jaiani; Narayanasamy Kanikkannan; Cheryl A Armstrong; John C Ansel; Mandip Singh
Journal:  Pharm Res       Date:  2004-01       Impact factor: 4.200

3.  IL-20 promotes cutaneous inflammation and peripheral itch sensation in atopic dermatitis.

Authors:  Zhiping Lu; Song Xiao; Weiwei Chen; Renkai Zhu; Hua Yang; Martin Steinhoff; Yanqing Li; Wenke Cheng; Xinrong Yan; Lianlian Li; Shanghai Xue; Ciara Larkin; Wenhao Zhang; Qianqian Fan; Ruizhen Wang; Jiafu Wang; Jianghui Meng
Journal:  FASEB J       Date:  2022-06       Impact factor: 5.834

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.